A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure.

Bradley, Jessica M

A novel fibroblast activation inhibitor attenuates left ventricular remodeling and preserves cardiac function in heart failure. [electronic resource] - American journal of physiology. Heart and circulatory physiology 09 2018 - H563-H570 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural

1522-1539

10.1152/ajpheart.00603.2017 doi


Animals
Cardiotonic Agents--pharmacology
Cells, Cultured
Collagen--metabolism
Heart Failure--drug therapy
Humans
Male
Mice
Mice, Inbred C57BL
Myofibroblasts--drug effects
Protein-Lysine 6-Oxidase--metabolism
Proto-Oncogene Proteins c-akt--metabolism
Ribosomal Protein S6 Kinases, 70-kDa--metabolism
STAT3 Transcription Factor--metabolism
Sulfonamides--chemistry
Transforming Growth Factor beta--metabolism
Ventricular Remodeling--drug effects